Breaking News

You are here » Indian-Commodity  :  Commodities  :  Copper  :  Copper futures end marginally lower on Wednesday

10-May2018

Copper futures end marginally lower on Wednesday

Copper futures ended marginally lower on Wednesday as investors were a bit cautious after the United States pulled out of an international nuclear deal with Iran. US President Donald Trump said he would re-impose US economic sanctions on Iran to undermine 'a horrible one-sided deal that should have never, ever been made'.

Copper futures for July delivery fell less than 0.1 percent to settle at $3.058 a pound on the Comex metals division of New York Mercantile Exchange. While, copper on the London Metal Exchange closed up 1 percent at $6,810 a metric ton.



Related News

View all news

Copper futures end higher on Wednesday

Copper futures ended higher on Wednesday. Meanwhile, base metals on London Metal Exchange held steady as weak retail sales data from top consumer China took the shine off upbeat industrial output and investment......

Copper futures end higher on Wednesday

Copper futures ended higher on Wednesday. Meanwhile, base metals on London Metal Exchange held steady as weak retail sales data from top consumer China took the shine off upbeat industrial output and investment......

Copper futures end higher on Tuesday

Copper futures ended higher on Tuesday as worries about growth in top consumer China receded after a report that the country's chief trade negotiator could visit the United States before a meeting between......

Top News

View all news

Karnataka Bank launches CASA campaign

Karnataka Bank has launched Current & Savings Accounts campaign (CASA) of FY 2018-19 and introduced a new SB scheme 'KBL SB - TASC' a specialized product for Trusts/Associates/Societies/Clubs.Under......

M&M's arm opens manufacturing hub in Bengaluru

Mahindra & Mahindra's (M&M) subsidiary -- Mahindra Electric Mobility has opened its electric technology manufacturing hub set up with an investment of Rs 100 crore in Bengaluru. The plant......

Venus Remedies reports positive result in Phase-3 Clinical Trials for ELORES

Venus Remedies has reported positive Top-Line results in its Phase-3 Clinical Trials for its flagship product ELORES. The results were presented at IDWeek 2018 in San Francisco. IDWeek is an annual scientific......